Inhibitors are complicated. But your treatment doesn't have to be. FEIBA prophylaxis can help you manage your hemophilia A or B with inhibitors and help you prevent bleeds.1 With dedication to your safety and support every step of the way.

Data callout icon: Learn about how effective FEIBA can be with routine prophylactic treatment

Results that speak for themselves

See how effective FEIBA was in routine prophylaxis treatment.

What if you could do more to prevent bleeds before they happen?
Sounds nice, doesn't it?

Understand inhibitors Discover FEIBA
Drop icon: Learn how FEIBA works

REDUCE bleeds. Increase "me time."

FEIBA can help you prevent bleeds and manage life with inhibitors. As a matter of fact, FEIBA is the only FDA-approved treatment indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in hemophilia A and B patients with inhibitors.1

Learn how FEIBA works
icon: Get connected to the right support

Find support. Share support.

Guess what? You're not alone. There's a world of people who understand what you're going through. See their stories, find walks and other ways to stay inspired, and stay strong. Together.

Learn how to take FEIBA
Sign up

Cookie Use Notification

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies
as set out in our cookie notice. Please read our cookie notice for more information on the cookies we use and how to delete or block the use of cookies.

      Find out more

See LessMore

What is FEIBA?

FEIBA is an Anti-Inhibitor Coagulant Complex approved for use in hemophilia A and B patients with inhibitors for:

  • Control and prevention of bleeding episodes

Detailed Important Risk Information

What is FEIBA?

FEIBA is an Anti-Inhibitor Coagulant Complex approved for use in hemophilia A and B patients with inhibitors for:

  • Control and prevention of bleeding episodes
  • Use around the time of surgery
  • Routine prophylaxis to prevent or reduce the frequency of bleeding episodes

Detailed Important Risk Information

  • Blood clots that block blood vessels and their effects have been reported during post-marketing surveillance following infusion of FEIBA, particularly following administration of high doses (above 200 units per kg per day) and/or in patients at risk for forming blood clots.
  • If you experience any of these side effects, call your doctor right away.
Toggle Important Safety Information
You’re now leaving this site.

Takeda does not review, endorse, or control the content of any non-Takeda site. Takeda is not responsible for the accuracy, content, practices, or standards of any non-Takeda resources accessed through a link on this site.

Takeda provides general information for educational purposes. This site does not provide medical advice, diagnosis, or treatment to you. Always consult your physician to help decide a treatment plan or other medical advice.

Continue Stay on Site
';